Federated Disease Staging

Maintains the temporal integrity of patient records by keeping all sequential scans and progression labels within the originating institution. Unlike cross-sectional federated learning, staging models must learn from ordered time-series data without ever aligning or exposing a patient's complete disease trajectory across visits.

• Prevents reconstruction of patient timelines through gradient inspection
• Applies differential privacy to temporal update sequences
• Ensures compliance with GDPR's right to privacy on longitudinal health data

Employs specialized loss functions that respect the inherent ordering of disease stages. Standard classification treats stages as independent categories, but staging requires the model to understand that Stage II is between Stage I and Stage III. Federated ordinal regression preserves these ranking constraints across sites.

• Uses cumulative link models adapted for federated optimization
• Penalizes misclassifications proportionally to severity distance
• Maintains consistent staging thresholds across heterogeneous scanner populations

Addresses the challenge of inconsistent follow-up intervals and visit schedules across institutions. A patient scanned monthly at one hospital and quarterly at another introduces temporal distribution shift that federated staging models must harmonize without direct data comparison.

• Implements time-aware aggregation that normalizes progression rates
• Uses federated calibration to align staging criteria across clinical sites
• Compensates for varying imaging intervals without sharing visit schedules

Extends beyond current-stage classification to predict the probability and velocity of disease advancement. Federated models learn from diverse progression patterns across populations, enabling personalized risk scores without pooling individual patient trajectories.

• Trains time-to-event models using federated survival analysis
• Outputs calibrated risk scores for short-term and long-term progression
• Incorporates censored data from patients lost to follow-up at each site

Jointly learns disease staging alongside related predictive tasks such as biomarker quantification or treatment response indicators. This multi-task approach improves staging accuracy by leveraging shared representations while keeping all labels decentralized.

• Simultaneously predicts stage and relevant lab values from imaging
• Federated gradient sharing across tasks without label aggregation
• Improves rare-stage detection through auxiliary task regularization

Adapts the global staging model to local population characteristics and clinical workflows through personalized federated learning techniques. A community hospital's patient demographics and disease prevalence may differ significantly from a tertiary referral center.

• Applies federated transfer learning for local fine-tuning
• Maintains global staging consistency while accommodating local priors
• Uses model distillation to compress global knowledge for edge deployment

A specialized federated paradigm designed for temporal patient data where each institution holds time-series records of the same patients over multiple visits. Unlike standard federated averaging, this approach must preserve within-subject correlations across time points while keeping each patient's complete timeline local.

• Handles irregular sampling intervals between hospital visits
• Maintains temporal ordering without sharing visit dates
• Critical for modeling disease trajectories in chronic conditions like Alzheimer's or cancer

A privacy-preserving extension of time-to-event modeling that predicts the probability of disease progression or mortality using censored data distributed across institutions. The model learns from patients who may drop out or have incomplete follow-up without centralizing sensitive outcome data.

• Uses Cox proportional hazards or deep survival models in a federated setting
• Handles right-censored data where patients are lost to follow-up
• Essential for oncology staging where overall survival is the ground truth

A specialized loss function and model architecture for predicting ordered categorical outcomes—precisely what disease staging requires. Stage I through Stage IV have a natural ordering that standard classification ignores. Federated ordinal regression preserves this ordinal relationship while training across institutions.

• Uses cumulative link models or ordinal cross-entropy loss
• Penalizes distant misclassifications more severely than adjacent ones
• Directly maps to clinical staging systems like TNM or Gleason scores

The broader category encompassing disease staging as a specific application. Prognosis prediction models forecast future clinical outcomes—including progression-free survival, treatment response, and quality of life metrics—directly from medical images without sharing patient follow-up data.

• Integrates imaging biomarkers with clinical covariates
• Enables multi-institutional validation of prognostic markers
• Supports personalized treatment planning based on predicted trajectories

A core challenge in federated disease staging where different institutions collect follow-up data at inconsistent time intervals or with varying visit frequencies. A model trained on quarterly scans at one hospital may fail on annual scans at another.

• Requires time-aware aggregation strategies during federated averaging
• May leverage temporal normalization or interpolation techniques
• Closely related to Non-IID data handling but with a temporal dimension

The decentralized extraction of quantitative imaging features—texture, shape, intensity—that serve as inputs to disease staging models. Radiomic features act as an intermediate representation, allowing staging algorithms to operate on compact feature vectors rather than raw images during federated training.

• Reduces communication overhead compared to image-based federated learning
• Enables standardized feature extraction via IBSI-compliant pipelines
• Links imaging phenotypes to disease progression without sharing DICOM data